COMPARISON OF THE INTERMEDIATE COMPLEXES OF HUMAN GROWTH-HORMONE BOUND TO THE HUMAN GROWTH-HORMONE AND PROLACTIN RECEPTORS

被引:74
|
作者
KOSSIAKOFF, AA [1 ]
SOMERS, W [1 ]
ULTSCH, M [1 ]
ANDOW, K [1 ]
MULLER, YA [1 ]
DEVOS, AM [1 ]
机构
[1] GENENTECH INC,DEPT PROT ENGN,S SAN FRANCISCO,CA 94080
关键词
CRYSTAL STRUCTURES; HUMAN GROWTH HORMONE; HUMAN PROLACTIN; MOLECULAR RECOGNITION PROCESSES; RECEPTORS;
D O I
10.1002/pro.5560031008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structures of complexes of human growth hormone (hGH) with the growth hormone and prolactin receptors (hGHR and hPRLR, respectively), together with the mutational data available for these systems, suggest that an extraordinary combination of conformational adaptability, together with finely tuned specificity, governs the molecular recognition processes operative in these systems. On the one hand, in the active 1:2 ligand-receptor complexes, 2 copies of the same receptor use the identical set of binding determinants to recognize topographically different surfaces on the hormone. On the other hand, comparing the 1:1 hGH-hGHR and hGH-hPRLR complexes, 2 distinct receptors use this same set of binding determinants to interact with the identical binding site on the ligand, even though few residues among the binding determinants are conserved. The structural evidence demonstrates that this versatility is accomplished by local conformational flexibility of the binding loops, allowing adaptation to different binding environments, together with rigid-body movements of the receptor domains, necessary for the creation of specific interactions with the same binding site.
引用
收藏
页码:1697 / 1705
页数:9
相关论文
共 50 条
  • [21] RADIOIMMUNOASSAY AND BIOASSAY OF HUMAN GROWTH-HORMONE AND HUMAN-PROLACTIN
    TANAKA, T
    SHISHIBA, Y
    GOUT, PW
    BEER, CT
    NOBLE, RL
    FRIESEN, HG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (01): : 18 - 20
  • [22] PARTIAL GROWTH-HORMONE DEFICIENCY - ENDOGENOUS GROWTH-HORMONE CONCENTRATION AND EFFECT OF EXOGENOUS HUMAN GROWTH-HORMONE
    BUTENANDT, O
    KLINISCHE WOCHENSCHRIFT, 1973, 51 (06): : 266 - +
  • [23] PROLACTIN AND GROWTH-HORMONE RECEPTORS - REGULATION AND CHARACTERIZATION
    FRIESEN, HG
    FEDERATION PROCEEDINGS, 1979, 38 (12) : 2610 - 2610
  • [24] THE DIFFERENT FORMS OF GROWTH-HORMONE AND PROLACTIN RECEPTORS
    FINIDORI, J
    SOTIROPOULOS, A
    GOUJON, L
    LEBRUN, JJ
    EDERY, M
    VINAY, MCP
    KELLY, P
    ANNALES D ENDOCRINOLOGIE, 1993, 54 (06) : 363 - 366
  • [25] GROWTH-HORMONE RADIOLIGAND ASSAY UNRESPONSIVE TO HUMAN PROLACTIN
    ETZRODT, H
    MUSCH, KA
    SCHLEYER, M
    PFEIFFER, EF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (06): : 1184 - 1187
  • [26] CULTURE OF HUMAN PITUITARY PROLACTIN AND GROWTH-HORMONE CELLS
    SNYDER, J
    HYMER, WC
    WILFINGER, WW
    CELL AND TISSUE RESEARCH, 1978, 191 (03) : 379 - 388
  • [27] IMMUNOCYTOCHEMICAL DEMONSTRATION OF HUMAN GROWTH-HORMONE AND PROLACTIN CELLS
    HALMI, NS
    PARSONS, JA
    ERLANDSEN, SL
    DUELLO, T
    ANATOMICAL RECORD, 1975, 181 (02): : 370 - 370
  • [28] DOSE DEPENDENCE OF GROWTH RESPONSE TO HUMAN GROWTH-HORMONE IN GROWTH-HORMONE DEFICIENCY
    PREECE, MA
    TANNER, JM
    WHITEHOUSE, RH
    CAMERON, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (03): : 477 - 483
  • [29] HUMAN PITUITARY GROWTH-HORMONE (HGH) THERAPY IN GROWTH-HORMONE DEFICIENCY
    FRASIER, SD
    ENDOCRINE REVIEWS, 1983, 4 (02) : 155 - 170
  • [30] COMPARISON OF HUMAN GROWTH-HORMONE (HGH) AND OXANDROLONE AS GROWTH STIMULATING AGENTS IN PATIENTS WITH GROWTH-HORMONE DEFICIENCY
    TATTONI, DS
    KELLEY, VC
    PEDIATRIC RESEARCH, 1974, 8 (04) : 375 - 375